X

XUND

MDR-certified SaMD for healthcare workflows

Overview

XUND develops MDR-certified Software as a Medical Device (SaMD) that digitises patient interactions from prevention to diagnosis for insurers, hospitals, and pharma. Its digital health assistant and Medical API help users understand symptoms and determine next steps, while its RAVE large language model layer supports healthcare workflows. The company operates with a team of 40+ across Vienna, Budapest, and London, and recently secured €6 million in a Pre-Series A to expand across the DACH region and the UK, strengthening SaMD and RAVE integrations. This positions XUND to streamline clinical pathways and data-driven care by providing compliant software tools that translate patient data into actionable medical guidance for healthcare providers and payers.

Work here?Claim your company

About XUND

Simplify's Rating
Not yet rated

We're working on gathering enough insights on this company, check back soon!

Industries

Enterprise SoftwareAI & Machine LearningHealthcare

Company Size

51-200

Company Stage

Seed

Total Funding

$17M

Headquarters

Vienna, Austria

Founded

2018

Get referred to XUND

See people who can refer or advise you

Funding

Total Funding

$17M

Above

Industry Average

Funded Over

5 Rounds

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Above Average

Industry standards

$3.3M
$2M
$2.3M
$3M
$6M

Benefits

  • Remote Work Options
  • Stock Options
  • Professional Development Budget
  • Company Social Events

Company News

EU-Startups
Dec 16th, 2025
Antwerp's Mindoo secures €5 million to reduce workload for hospital and medical staff using AI agents

Antwerp's Mindoo secures €5 million to reduce workload for hospital and medical staff using AI agents. Mindoo, a Belgian platform deploying safe and governed agentic workflows in healthcare, announced today that it has secured €5 million in Seed financing to provide hospitals and practices with a scalable AI workforce layer that performs routine tasks and alleviates pressure. The round was raised from 6DC, Syndicate One and a group of strategic angel investors. "We learned very quickly that workflows in healthcare cannot be adapted to a product. The product has to adapt to existing workflows," said Gauthier Willemse, CEO and co-founder. "That is why Mindoo lets hospital teams configure and run their own agents, so automation fits naturally into how they already work." In 2025, EU-Startups has reported several funding rounds across European healthcare and AI-enabled workflow automation, providing context for Mindoo's Seed round. These include Jutro Medical, a Warsaw-based AI-first primary care provider, which raised a €24 million Series A extension to scale AI-supported clinical operations; XUND, which secured €6 million to strengthen its AI-powered healthcare platform; and Helsinki-based Elea, which raised €4 million to accelerate diagnostic workflows using AI. Earlier-stage rounds include Punto Health in the UK, which raised €2.3 million to scale its AI-enabled dementia care platform. In Belgium specifically, EU-Startups has also covered Cavell, which raised €1.5 million to improve healthcare efficiency through digital tools, and Brussels-linked Model Health, which secured €800k in pre-Seed funding for AI-based movement analysis in clinical settings. Excluding Mindoo, these rounds represent approximately €38 million invested into adjacent healthcare AI and digital health segments during 2025. Against this backdrop, Mindoo's €5 million Seed financing positions the Belgian company within a broader European pattern of investment focused on applying AI to operational and clinical workflows rather than experimental use cases. While larger rounds such as Jutro Medical's reflect capital-intensive care delivery models, smaller Seed and pre-Seed financings across Finland, Belgium and the UK indicate sustained investor interest in modular, workflow-oriented AI tools for healthcare organisations. "We designed Mindoo so healthcare organisations can deploy agents that follow their rules, integrate with their systems and behave predictably in real-world environments," added Bart Lens, CTO and co-founder. "This is how AI becomes operational, not experimental." Founded in 2025, Mindoo is a healthcare AI company that claims to provide hospitals and medical practices with a safe, governed platform for agentic workflow automation. Mindoo's configurable AI agents perform structured intake, documentation drafting, follow-up communication and front-desk workflows, helping healthcare organisations increase capacity without increasing headcount. The company outlines that healthcare organisations face a widening gap between available staff and rising care demand. Many workflows remain uncaptured or incomplete simply because teams do not have the capacity to handle them. Mindoo looks to address this by providing configurable AI agents that hospital teams use to handle structured intake, documentation drafting, follow-up interactions and front-desk communication within a single platform. Mindoo currently offers four core agents that hospitals can configure to reflect their own protocols, languages and specialty workflows: * Receptionist agent for handling routine patient communication and registrations * Pre-visit agent for structured intake and medical history * Scribe agent for drafting notes, letters and orders * Follow-up agent for post-visit communication and care pathways "We invested in Mindoo because the founders understand healthcare from the inside and have built a platform that lets hospitals adopt AI responsibly. The opportunity ahead is enormous. Automated workflows will become essential infrastructure for healthcare," Lucas Stoops, Partner at 6 Degrees Capital. Mindoo is already deployed in hospitals across Belgium and Germany and supports integration with EHR systems. Expansion to the Netherlands and France will follow as new reference sites go live. The funding will support Mindoo in strengthening its platform, bringing its four core agents to full production maturity across multiple specialties and expanding the team with engineers, clinical specialists and deployment experts.

EU-Startups
Mar 5th, 2025
HealthTech startup XUND secures €6 million to strengthen European leadership in AI-powered healthcare | EU-Startups

Vienna-based HealthTech scaleup XUND, which specialises in building Software as a Medical Device (SaMD), has successfully closed a €6 million pre-Series A

Trending Topics
Mar 5th, 2025
XUND secures €6M for European expansion

XUND, a MedTech scale-up founded in 2018, secured €6 million in a Pre-Series A round led by Lead Ventures and J&T Ventures. This funding will accelerate XUND's expansion in Europe, focusing on the DACH region and the UK. The company aims to enhance its AI-driven SaMD solutions and integrate its new LLM solution, RAVE. XUND has raised a total of €10 million since 2020, with previous rounds including a €6 million seed round in September 2022 and an additional €2 million in May 2024.

Coverager
Apr 4th, 2024
Massmutual Backs Xund

XUND <i class="fa fa-info-circle company-popover" data-content="h3XUND/h3. div. table

Brown Brothers Media
Apr 2nd, 2024
Austrian health tech scale-up Xund extends seed round funding to €8M to digitise the patient journey: Here's how

New investor Thieme Group participated in the funding round, along with existing investors, including MMC Ventures and MassMutual Ventures.

Recently Posted Jobs

Sign up to get curated job recommendations

XUND is Hiring for 1 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs